Polaryx Therapeutics, Inc. (PLYX)
NASDAQ: PLYX · Real-Time Price · USD
6.39
-0.07 (-1.08%)
At close: Apr 16, 2026, 4:00 PM EDT
6.58
+0.19 (2.93%)
After-hours: Apr 16, 2026, 6:17 PM EDT
Polaryx Therapeutics Market Cap
Polaryx Therapeutics has a market cap or net worth of $302.52 million as of April 16, 2026.
Market Cap
302.52M
Enterprise Value
296.91M
1-Year Change
n/a
Ranking
Category
Stock Price
$6.39
Market Cap Chart
Since February 2, 2026, Polaryx Therapeutics's market cap has decreased from $1.66B to $302.52M, a decrease of -81.74%. That is a compound annual growth rate of -99.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 305.84M | -0.15% |
| Apr 14, 2026 | 306.31M | 4.86% |
| Apr 13, 2026 | 292.11M | 8.63% |
| Apr 10, 2026 | 268.91M | -1.39% |
| Apr 9, 2026 | 272.70M | 0.35% |
| Apr 8, 2026 | 271.75M | 11.24% |
| Apr 7, 2026 | 244.29M | -9.95% |
| Apr 6, 2026 | 271.28M | -19.75% |
| Apr 2, 2026 | 338.03M | -6.05% |
| Apr 1, 2026 | 359.81M | 0.53% |
| Mar 31, 2026 | 357.92M | 14.37% |
| Mar 30, 2026 | 312.94M | -15.15% |
| Mar 27, 2026 | 368.80M | 22.10% |
| Mar 26, 2026 | 302.05M | 1.59% |
| Mar 25, 2026 | 297.32M | -2.48% |
| Mar 24, 2026 | 304.89M | 16.67% |
| Mar 23, 2026 | 261.33M | -0.36% |
| Mar 20, 2026 | 262.28M | -1.95% |
| Mar 19, 2026 | 267.49M | 2.17% |
| Mar 18, 2026 | 261.81M | -1.78% |
| Mar 17, 2026 | 266.54M | -0.88% |
| Mar 16, 2026 | 268.91M | -10.69% |
| Mar 13, 2026 | 301.10M | 36.77% |
| Mar 12, 2026 | 220.15M | -19.27% |
| Mar 11, 2026 | 272.70M | -3.52% |
| Mar 10, 2026 | 282.64M | 69.60% |
| Mar 9, 2026 | 166.65M | 28.47% |
| Mar 6, 2026 | 129.72M | 4.58% |
| Mar 5, 2026 | 124.04M | -6.09% |
| Mar 4, 2026 | 132.09M | -0.36% |
| Mar 3, 2026 | 132.56M | -2.78% |
| Mar 2, 2026 | 136.35M | -5.57% |
| Feb 27, 2026 | 144.40M | -4.39% |
| Feb 26, 2026 | 151.03M | 15.16% |
| Feb 25, 2026 | 131.14M | -1.07% |
| Feb 24, 2026 | 132.56M | 13.36% |
| Feb 23, 2026 | 116.94M | -5.36% |
| Feb 20, 2026 | 123.57M | -2.25% |
| Feb 19, 2026 | 126.41M | -7.61% |
| Feb 18, 2026 | 136.82M | -27.02% |
| Feb 17, 2026 | 187.48M | 64.32% |
| Feb 13, 2026 | 114.10M | -17.47% |
| Feb 12, 2026 | 138.24M | -19.34% |
| Feb 11, 2026 | 171.38M | -19.56% |
| Feb 10, 2026 | 213.04M | -24.11% |
| Feb 9, 2026 | 280.75M | -33.45% |
| Feb 6, 2026 | 421.83M | -44.31% |
| Feb 5, 2026 | 757.49M | -28.89% |
| Feb 4, 2026 | 1.07B | 2.51% |
| Feb 3, 2026 | 1.04B | -37.29% |
| Feb 2, 2026 | 1.66B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AC Immune | 311.49M |
| Abeona Therapeutics | 308.06M |
| Inhibikase Therapeutics | 305.06M |
| Cellectis | 304.73M |
| Avalo Therapeutics | 304.23M |
| NovaBridge Biosciences | 300.69M |
| LENZ Therapeutics | 300.38M |
| Anavex Life Sciences | 300.26M |